Iveco Group N.V. (0AB5)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 6.373 |
|---|---|
| 52-week range | 6.373 – 14.490 |
| Return, 1 month / 3 months | −54.8% / −54.2% |
| Return, 1 year / 3 years | −50.4% / +21.0% |
| Trend | Below its 200-day average |
| RSI (14) | 3 |
| Volatility (1 year) | 81.1% |
| Worst drawdown (1 year) | -55.8% |
| Average daily value traded | 7.93M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Iveco Group N.V. is a commercial vehicle manufacturer based in Turin, Italy. It builds light, medium and heavy trucks under the Iveco brand, along with city and intercity buses through its bus operations, and specialty vehicles for defence, firefighting and other demanding uses. The company also supplies powertrains and related components and provides financing services to support vehicle purchases. Its customers are mainly transport operators, hauliers, public transit authorities, fleets and industrial users across Europe and other markets.
On this site Iveco Group N.V. appears as a stock on the London Exchange (UK), code 0AB5, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Iveco Group N.V. (0AB5) trades on the London Exchange in UK. It last closed at EUR 6.373 on 23 October 2026.
Its price-based Market X-Ray is 26 out of 100 (a weak price profile), ranking 3,252 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 50.4% and over the last three months it fell 54.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 16 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -53.0% | ||
| From 52-week high | -55.8% | ||
| Momentum | 21 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -54.2% | ||
| 6-month return | -54.4% | ||
| 12-month return, skipping the last month | 9.6% | ||
| Stability (higher is calmer) | 13 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 81.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -55.8% | ||
| Liquidity | 72 · Strong | Trades actively. | |
| Average daily value traded | 7.93M EUR | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −54.8% |
| 3 months | −54.2% |
| 6 months | −54.4% |
| 1 year | −50.4% |
| 3 years | +21.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 13.181 / 13.568 |
|---|---|
| Golden / death cross (60 days) | Death, 3 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.904 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Apr 2026 | EUR 5.8216 |
| 22 Apr 2025 | EUR 0.3300 |
| 22 Apr 2024 | EUR 0.2200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.